|
FREE patent keyword monitoring and additional FREE benefits. |
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Ether Doai > Benzene Ring Containing > Plural Oxygens > Acyclic Carbon To Carbon Unsaturation Acyclic Carbon To Carbon UnsaturationAcyclic Carbon To Carbon Unsaturation patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/18/07 - 20070015840 - Use of an alkyl ether of hydroxystilbene for the treatment of dry skin The present invention relates to a method for the cosmetic treatment of dry skin or of a dry scalp, comprising the topical application to the skin or the scalp of a composition containing, in a physiologically acceptable medium, at least one alkyl ether of hydroxystilbene with a saturated or unsaturated, ... 06/22/06 - 20060135625 - Method of administering split doses of a vascular targeting agent The present invention is directed to the use of vascular targeting agents or pharmaceutically acceptable salts thereof for administration in divided doses to a warm-blooded animal, such as a human. Also disclosed is a medicament comprising two or more fraction of doses of a vascular targeting agent, or a pharmaceutically ... 04/27/06 - 20060089415 - Anti-infective agents and methods of use wherein A, B and R1, R2, R5, R6, and R7 are independently selected from a group consisting of H, alkyl and aryl groups and R11 is an alkyl or an aryl group. ... 12/08/05 - 20050272825 - Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof. ... 12/08/05 - 20050272824 - Methods for monitoring combretastatin resistance Methods and diagnostic kits for monitoring combretastatin resistance are provided. ... 08/25/05 - 20050187302 - Method for treatment or prevention of osteoporosis in individuals with high bone turnover This invention relates to a method for the treatment or prevention of osteoporosis in an individual suffering from increased bone turnover, said method comprising administering to said individual an effective amount of a therapeutically active compound, which is a selective estrogen receptor modulator of the triphenylalkene or triphenylalkane structure. ... 08/25/05 - 20050187301 - Solid formulations of ospemifene or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients. ... 08/18/05 - 20050182143 - Method for enhancing the bioavailability of ospemifene or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food. ... ### FreshPatents.com Support |